Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome

Free Subscription Articles published in Scand J Gastroenterol Retrieve available abstracts of 20 articles: HTML format

Single Articles

August 2025
1. MADVA EN, Varma S, Small V, Dekel M, et al
   Pharmacologic neuromodulation for bloating.
   Scand J Gastroenterol. 2025 Aug 8:1-5. doi: 10.1080/00365521.2025.2544306.
   PubMed     Abstract available
   
   
   July 2025
2. ROTH B, Al-Shareef D, Ohlsson B
   Intake of fiber and micronutrients in patients with IBS.
   Scand J Gastroenterol. 2025 Jul 22:1-12. doi: 10.1080/00365521.2025.2535721.
   PubMed     Abstract available
   
   
   May 2025
3. SANDBERG-JANZON A, Karling P
   Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study.
   Scand J Gastroenterol. 2025 May 29:1-8. doi: 10.1080/00365521.2025.2512368.
   PubMed     Abstract available
   
   
   January 2025
4. SANDBERG-JANZON A, Karling P
   Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population.
   Scand J Gastroenterol. 2025 Jan 25:1-9. doi: 10.1080/00365521.2025.2458070.
   PubMed     Abstract available
   
   
   
5. CYMBAL M, Chatterjee A, Ajayi-Fox P, Lyu R, et al
   Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome.
   Scand J Gastroenterol. 2025 Jan 24:1-5. doi: 10.1080/00365521.2025.2456491.
   PubMed     Abstract available
   
   
   September 2024
6. DALE HF, Hagen M, Bekkelund M, Deb C, et al
   Disaccharidase deficiencies and gastrointestinal symptoms in patients referred to gastroscopic examination: a single center study from Norway.
   Scand J Gastroenterol. 2024 Sep 4:1-6. doi: 10.1080/00365521.2024.2395848.
   PubMed     Abstract available
   
   
   April 2024
7. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
   A comparison of Swedish IBS patients and general practitioners regarding viewpoints on IBS: a Q-methodology study.
   Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2328590.
   PubMed     Abstract available
   
   
   
8. EL-SALHY M, Gilja OH, Hatlebakk JG
   Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
   Scand J Gastroenterol. 2024;59:391-400.
   PubMed     Abstract available
   
   
   November 2023
9. ALIHOSSEINI S, Khodaei F, Jaberinezhad M, Azari M, et al
   Evaluation of gallbladder contractility and Doppler findings in patients with irritable bowel syndrome; a case-control study.
   Scand J Gastroenterol. 2023 Nov 30:1-8. doi: 10.1080/00365521.2023.2287989.
   PubMed     Abstract available
   
   
   September 2023
10. BILLING J, Berentsen B, Lundervold A, Hillestad EMR, et al
    Cognitive function in patients with irritable bowel syndrome: impairment is common and only weakly correlated with depression/anxiety and severity of gastrointestinal symptoms.
    Scand J Gastroenterol. 2023 Sep 20:1-9. doi: 10.1080/00365521.2023.2256916.
    PubMed     Abstract available
    
    
    August 2023
11. SJODAHL J, Ingemansson A, Bureychak T, Norlin AK, et al
    Defecation symptoms in primary health care patients with irritable bowel syndrome.
    Scand J Gastroenterol. 2023 Aug 23:1-9. doi: 10.1080/00365521.2023.2248538.
    PubMed     Abstract available
    
    
    June 2023
12. DALE HF, Lorentzen SCS, Mellin-Olsen T, Valeur J, et al
    Diet-microbiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach.
    Scand J Gastroenterol. 2023 Jun 29:1-12. doi: 10.1080/00365521.2023.2228955.
    PubMed     Abstract available
    
    
    February 2023
13. STEINSVIK EK, Hausken T, Fluge O, Mella O, et al
    Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scand J Gastroenterol. 2023 Feb 2:1-8. doi: 10.1080/00365521.2023.2173533.
    PubMed     Abstract available
    
    
    
14. TORNKVIST NT, Backman AS, Linder M, Altman M, et al
    Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study.
    Scand J Gastroenterol. 2023 Feb 1:1-9. doi: 10.1080/00365521.2023.2173021.
    PubMed     Abstract available
    
    
    October 2022
15. HONG G, Li Y, Yang M, Li G, et al
    Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Scand J Gastroenterol. 2022 Oct 25:1-10. doi: 10.1080/00365521.2022.2136013.
    PubMed     Abstract available
    
    
    August 2022
16. YAN X, Wang J, Bai Y
    Potentials of circSOBP in the diagnosis and prognosis of gastric cancer.
    Scand J Gastroenterol. 2022 Aug 20:1-5. doi: 10.1080/00365521.2022.2088246.
    PubMed     Abstract available
    
    
    April 2022
17. EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
    The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725.
    PubMed     Abstract available
    
    
    
18. HEDSTROM A, Kvarnstrom M, Lindberg G, Alsabeah S, et al
    High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency.
    Scand J Gastroenterol. 2022 Apr 24:1-7. doi: 10.1080/00365521.2022.2065888.
    PubMed     Abstract available
    
    
    March 2022
19. WALLEN H, Ljotsson B, Svanborg C, Rydh S, et al
    Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study.
    Scand J Gastroenterol. 2022 Mar 9:1-8. doi: 10.1080/00365521.2022.2047220.
    PubMed     Abstract available
    
    
    
20. TOUNY AA, Kenny E, Mansson M, Webb DL, et al
    Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics.
    Scand J Gastroenterol. 2022 Mar 2:1-9. doi: 10.1080/00365521.2022.2041084.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.